Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$72.5 - $100.68 $4.91 Million - $6.82 Million
-67,700 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $830,208 - $1.14 Million
9,200 Added 15.73%
67,700 $6.46 Million
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $327,810 - $487,445
3,500 Added 6.36%
58,500 $7.27 Million
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $6.41 Million - $8.53 Million
55,000 New
55,000 $7.25 Million
Q3 2020

Nov 13, 2020

SELL
$72.92 - $102.01 $1.67 Million - $2.34 Million
-22,900 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$55.75 - $92.75 $1.28 Million - $2.12 Million
22,900 New
22,900 $1.99 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $3.47 Million - $4.7 Million
-38,400 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$61.98 - $96.5 $5.93 Million - $9.24 Million
-95,750 Reduced 71.38%
38,400 $3.33 Million
Q4 2018

Feb 12, 2019

SELL
$56.04 - $82.66 $7.11 Million - $10.5 Million
-126,900 Reduced 48.61%
134,150 $8.47 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $10.5 Million - $17.5 Million
-217,599 Reduced 45.46%
261,050 $20.6 Million
Q2 2018

Aug 13, 2018

SELL
$37.84 - $69.96 $3.61 Million - $6.67 Million
-95,400 Reduced 16.62%
478,649 $28.6 Million
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $15.2 Million - $22 Million
381,599 Added 198.28%
574,049 $23.2 Million
Q4 2017

Feb 13, 2018

BUY
$46.49 - $60.51 $3.48 Million - $4.53 Million
74,900 Added 63.72%
192,450 $10.1 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $4.36 Million - $5.54 Million
117,550
117,550 $5.54 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.76B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.